Camlin Fine Sciences Limited (BOM:532834)

Camlin Fine Sciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	276.27	-1,390	-927.53	521.06	606.78
Depreciation & Amortization	682.4	609.58	772.98	618.27	553.3
Other Amortization	26.8	-	13.08	6.86	6.34
Loss (Gain) From Sale of Assets	-1,016	1,491	1.45	0.65	2.33
Asset Writedown & Restructuring Costs	-	-	498.04	96.78	-
Loss (Gain) on Equity Investments	-16.62	-4.42	-	-	1.33
Stock-Based Compensation	19.74	2.8	0.09	23.59	73.89
Provision & Write-off of Bad Debts	137.5	20.68	-19.49	31.27	-36.28
Other Operating Activities	-237.67	2,421	2,313	598.37	205.07
Change in Other Net Operating Assets	365.73	-821.49	316.71	-1,388	41.7
Operating Cash Flow	820.69	229.96	1,390	508.98	1,454
Operating Cash Flow Growth	256.88%	-83.45%	173.06%	-65.01%	23.91%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-575.66	-424.47	-605.76	-1,443	-2,138
Sale of Property, Plant & Equipment	-	-	5.58	9.01	-
Cash Acquisitions	-	-	-	-	-655.36
Investment in Securities	295.61	-345.76	-77.09	-7.33	284.99
Other Investing Activities	-249.46	16.73	12.29	295.7	16.98
Investing Cash Flow	-529.52	-753.5	-664.98	-1,246	-2,491

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	-	1.78	522.74	-
Long-Term Debt Issued	689.48	-	250.35	808.43	1,058
Total Debt Issued	689.48	-	252.13	1,331	1,058
Short-Term Debt Repaid	-171.6	-108.11	-	-	-297.15
Long-Term Debt Repaid	-164	-665.38	-108.55	-82.17	-88.26
Total Debt Repaid	-335.59	-773.49	-108.55	-82.17	-385.41
Net Debt Issued (Repaid)	353.89	-773.49	143.58	1,249	672.34
Issuance of Common Stock	5.38	2,231	5.8	5.46	948.44
Preferred Dividends Paid	-	-	-281.31	-138.51	-
Dividends Paid	-	-	-281.31	-138.51	-
Other Financing Activities	-605.59	-696.07	-727.79	-519.36	-261.08
Financing Cash Flow	-246.32	761.7	-859.72	596.58	1,360

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-0	-	0	-
Net Cash Flow	44.85	238.16	-134.88	-140.69	322.92

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	245.03	-194.51	784.06	-934.11	-683.4
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	1.42%	-1.19%	5.39%	-5.56%	-4.84%
Free Cash Flow Per Share	1.28	-1.12	4.58	-5.51	-4.76
Levered Free Cash Flow	174.97	406.63	1,163	-1,758	-560.66
Unlevered Free Cash Flow	554.61	840.18	1,556	-1,514	-365.84

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	605.59	696.07	727.79	519.36	253.95
Cash Income Tax Paid	236.51	381.66	475.34	201.97	303.7
Change in Working Capital	365.73	-821.49	316.71	-1,388	41.7

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error